Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: PTSC's main income potential expires in 3.5 years. Toxic

I don't think you can estimate PTSC's value using the normal tools of eps x some multiple. You have to look at any PTSC investment as the equivalent of some type of savings instrument which has a beginning and end, like a cd. The interest rates available today are not much. But if PTSC is going to disburse whatever they make over the balance of the patent earnings life, then people will pay steep premiums for the privelege of being able to get those divys. Obviously much depends on licensing gaining needed tranction and the expectations going forward.

IMO, Opty

Share
New Message
Please login to post a reply